"Designing Growth Strategies is in our DNA"

U.S. Oncology Drugs Market Size, Share, Analysis, By Drugs Class (Cytotoxic Drugs {Alkylating Agents, Antimetabolites, and Others}, Targeted Drugs {Monoclonal Antibodies, and Others}, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid {Tablets and Capsules}, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, and Retail and Online Pharmacies), and Country Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108499

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Cancers, 2023
    2. Pipeline Analysis, Key Players
    3. Key Industry Developments: Mergers, Acquisitions, New Product Launches, Etc.
    4. Regulatory & Reimbursement Scenario, By Key Countries
    5. Impact of COVID-19 on the Market
  5. U.S. Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail and Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Genentech, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Novartis AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Bristol Myers Squibb Company
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. GlaxoSmithKline plc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Eli Lilly and Company
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developmnts
        5. Strategies
        6. financials (Based on Availability)
      8. AstraZeneca
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Sanofi
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Bayer AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Merck & Co., Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Oncology Drugs Market Revenue Breakdown (USD billion, %) by Drug Class, 2024 & 2032

Figure 2:  U.S. Oncology Drugs Market Value Share (%), by Drug Class, 2024 & 2032

Figure 3:  U.S. Oncology Drugs Market Value Share (%), by Therapy, 2024 & 2032

Figure 4:  U.S. Oncology Drugs Market Value Share (%), by Indication, 2024 & 2032

Figure 5:  U.S. Oncology Drugs Market Value Share (%), by Dosage Form, 2024 & 2032

Figure 6:  U.S. Oncology Drugs Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 7:  U.S. Oncology Drugs Market Share (%), By Company, 2023

Table 1:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 2:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019-2032

Table 3:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019-2032

Table 4:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2032

Table 5:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 6:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2032

U.S. Oncology Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 90
Consulting Services
    How will you benefit from our consulting services ?